The importance of endothelin-1 for microvascular dysfunction in diabetes

References

• AbassiZATateJEGolombE1992Role of neutral endopeptidase in the metabolism of endothelinHypertension2089951618556
   PubMed Web of Science ®Google Scholar
• AhlborgGLindströmJ2002Insulin sensitivity and big ET-1 conversion to ET-1 after ETA- or ETB-receptor blockade in humansJ Appl Physiol9321122112391119
   PubMed Web of Science ®Google Scholar
• AkGBuyukberberSSevincA2001The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with type 2 diabetes mellitusJ Diabetes Complications15150711358684
   PubMed Web of Science ®Google Scholar
• AnfossiGRussoIDoronzoG2007Relevance of the vascular effects of insulin in the rationale of its therapeutical useCardiovasc Hematol Disord Drug Targets72284918220724
   PubMedGoogle Scholar
• AnggardEGaltonSRaeG1989The fate of radioiodinated endothelin-1 and endothelin-3 in the ratJ Cardiovasc Pharmacol13S46S492473326
   PubMed Web of Science ®Google Scholar
• Berti-MatteraLNGariepyCEBurkeRM2006Reduced expression of endothelin B receptors and mechanical hyperalgesia in experimental chronic diabetesExp Neurol20139940616806184
   PubMed Web of Science ®Google Scholar
• BoultonAJScarpelloJHWardJD1982Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting?Diabetologia22687060849
   PubMed Web of Science ®Google Scholar
• CaballeroAEAroraSSaouafR1999Microvascular and macro-vascular reactivity is reduced in subjects at risk for type 2 diabetesDiabetes4818566210480619
   PubMed Web of Science ®Google Scholar
• CameronNECotterMALowPA1991Nerve blood flow in early experimental diabetes in rats: relation to conduction deficitsAm J Physiol261E1E81858864
   PubMed Web of Science ®Google Scholar
• CameronNECotterMA1995Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agentsJ Clin Invest961159637635953
   PubMed Web of Science ®Google Scholar
• CandidoRAllenTJ2002Haemodynamics in microvascular complications in type 1 diabetesDiabetes Metab Res Rev1828630412203944
   PubMed Web of Science ®Google Scholar
• CardilloCKilcoyneCMCannonRO2000Increased activity of endogenous endothelin in patients with hypercholesterolemiaJ Am Coll Cardiol361483811079646
   PubMed Web of Science ®Google Scholar
• CardilloCKilcoyneCMWaclawiwM1999Role of endothelin in the increased vascular tone of patients with essential hypertensionHypertension33753810024340
   PubMed Web of Science ®Google Scholar
• ChadeARKrierJDTextorSC2006Endothelin-A receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemiaJ Am Soc Nephro173394403
   PubMed Web of Science ®Google Scholar
• ChakrabartiSGanXTMerryA1998Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetesCurr Eye Res1730179543639
   PubMed Web of Science ®Google Scholar
• ChakrabartiSSimaAA1997Endothelin-1 and endothelin-3-like immuno-reactivity in the eyes of diabetic and non-diabetic BB/W ratsDiabetes Res Clin Pract37109209279481
   PubMed Web of Science ®Google Scholar
• CooperME1998Pathogenesis, prevention, and treatment of diabetic nephropathyLancet3529123213199683226
   PubMed Web of Science ®Google Scholar
• CowburnPJClelandJGMcArthurJD1999Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunctionJ Am Coll Cardiol33932810091818
   PubMed Web of Science ®Google Scholar
• CreagerMALuscherTFCosentinoF2003Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part ICirculation10815273214504252
   PubMed Web of Science ®Google Scholar
• De MattiaGCassone-FaldettaMBelliniC1998Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathyAm J Hypertens1198389715792
   PubMed Web of Science ®Google Scholar
• DonatelliMCollettiIBucaloML1994Plasma endothelin levels in NIDDM patients with macroangiopathyDiabetes Res25159647648786
   PubMedGoogle Scholar
• FagrellBJorneskogGIntagliettaM1999Disturbed microvascular reactivity and shunting – a major cause for diabetic complicationsVasc Med4125710512590
   PubMed Web of Science ®Google Scholar
• FeganPGTookeJEGoodingKM2003Capillary pressure in subjects with type 2 diabetes and hypertension and the effect of antihypertensive therapyHypertension4111111712695416
   PubMed Web of Science ®Google Scholar
• GallMARossingPSkottP1991Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patientsDiabetologia34655611955098
   PubMed Web of Science ®Google Scholar
• GianniniCDyckPJ1995Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severityAnn Neurol374985047717686
   PubMed Web of Science ®Google Scholar
• GokinAPFareedMUPanHL2001Local injection of endothelin-1 produces pain-like behaviour and excitation of nociceptors in ratsJ Neurosci2153586611438612
   PubMed Web of Science ®Google Scholar
• GroopPHForsblomCThomasMC2005Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetesNat Clin Pract Endocrinol Metab11001016929378
   PubMedGoogle Scholar
• GundersenHJG1974Peripheral blood flow and metabolic control in juvenile diabetesDiabetologia10225314845723
   PubMed Web of Science ®Google Scholar
• HalcoxJPNourKRZalosG2001Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockadeCirc Res899697611717152
   PubMed Web of Science ®Google Scholar
• JaapAJHammersleyMSShoreAC1994Reduced microvascular hyper-aemia in subjects at risk of developing type 2 (non-insulin-dependent) diabetes mellitusDiabetologia37214168163058
   PubMed Web of Science ®Google Scholar
• JanssonP-A2007Endothelial dysfunction in insulin resistance and type 2 diabetesJ Intern Med2621738317645585
   PubMed Web of Science ®Google Scholar
• JarvisMFWessaleJLZhuCZ2000ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile allodynia in a diabetic rat model of neuropathic painEur J Pharmacol388293510657544
   PubMed Web of Science ®Google Scholar
• JeffcoateWJHardingKG2003Diabetic foot ulcersLancet36115455112737879
   PubMed Web of Science ®Google Scholar
• JohnströmPFryerTDRichardsHK2005Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ET B receptors in vivoBr J Pharmacol1441152215644875
   PubMed Web of Science ®Google Scholar
• JörneskogGBrismarKFagrellB1995Skin capillary circulation is more impaired in toes of diabetic than non-diabetic patients with peripheral vascular diseaseDiabet Med1236417712701
   PubMed Web of Science ®Google Scholar
• JörneskogGBrismarKFagrellB1998Pronounced skin capillary ischemia in the feet of diabetic patients with bad metabolic controlDiabetologia41410159562344
   PubMed Web of Science ®Google Scholar
• JörneskogGKalaniMKuhlJ2005Early microvascular dysfunction in healthy normal-weight males with heredity for type 2 diabetesDiabetes Care281495715920077
   PubMed Web of Science ®Google Scholar
• JörneskogG1995Functional Microangiopathy in the Digital Skin of Patients with Diabetes Mellitus [dissertation]Stockholm, SwedenKarolinska Institute
   Google Scholar
• KalaniMBrismarKFagrellB1999Transcutaneous oxygen tension and toe blood pressure as predictors for outcome of diabetic foot ulcersDiabetes Care221475110333917
   PubMed Web of Science ®Google Scholar
• KalaniMPernowJBragdJ2008Improved peripheral perfusion during endothelin-A receptor blockade in patients with type 2 diabetes and critical limb ischemiaDiabetes Care31e5618594055
   PubMedGoogle Scholar
• KalaniMSilveiraABlombäckM2007Beneficial effects of dalteparin on haemostatic function and local tissue oxygenation in patients with diabetes, severe vascular disease and foot ulcersThromb Res1206536117275886
   PubMed Web of Science ®Google Scholar
• KhanZAChakrabartiS2003Endothelins in chronic diabetic complicationsCan J Physiol Pharmacol816223412839273
   PubMed Web of Science ®Google Scholar
• KingHAubertREHermanWH1998Global burden of diabetes 1995–2025: prevalence, numerical estimates and projectionsDiabetes Care211414319727886
   PubMed Web of Science ®Google Scholar
• KohanDE1997Endothelins in the normal and diseased kidneyAm J Kidney Dis292269002526
   PubMed Web of Science ®Google Scholar
• KohnerEMPatelVRassamSM1995Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathyDiabetes4460377789621
   PubMed Web of Science ®Google Scholar
• KyriakidesZSKremastinosDTBofilisE2000Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriographyHeart841768210908255
   PubMed Web of Science ®Google Scholar
• LeeYJShinSJTsaiJH1994Increased urinary endothelin-1-like immunoreactivity in NIDDM patients with albuminuriaDiabetes Care1726368026280
   PubMed Web of Science ®Google Scholar
• LiLFinkGDWattsSW2003Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertensionCirculation1071053812600921
   PubMed Web of Science ®Google Scholar
• LoveMPFerroCJHaynesWG2000Endothelin receptor antagonism in patients with chronic heart failureCardiovasc Res471667210869543
   PubMed Web of Science ®Google Scholar
• LowPALagerlundTDMcManisPG1989Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathyInt Rev Neurobiol313554382557297
   PubMed Web of Science ®Google Scholar
• LuscherTFCreagerMABeckmanJA2003Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IICirculation10816556114517152
   PubMed Web of Science ®Google Scholar
• MasuzawaKJesminSMaedaS2006Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retinaExp Biol Med23110904
   Web of Science ®Google Scholar
• MatherKJMirzamohammadiBLteifA2002Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetesDiabetes5135172312453909
   PubMed Web of Science ®Google Scholar
• MolenaarPO’ReillyGSharkeyA1993Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardiumCirc Res72526387679333
   PubMed Web of Science ®Google Scholar
• NohriaAGarrettLJohnsonW2003Endothelin-1 and vascular tone in subjects with atherogenic risk factorsHypertension4243812756218
   PubMed Web of Science ®Google Scholar
• PangIHYorioT1997Ocular actions of endothelinsProc Soc Exp Biol Med21521349142135
   PubMed Web of Science ®Google Scholar
• PernowJBohmFJohanssonBL2000Enhanced vasoconstrictor response to endothelin-B-receptor stimulation in patients with atherosclerosisJ Cardiovasc Pharmacol36S418S2011078438
   PubMed Web of Science ®Google Scholar
• ProperziGTerenghiGGuXH1995Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients; a quantitative immunohistochemical studyJ Pathol175243527738721
   PubMed Web of Science ®Google Scholar
• Rask-MadsenCKingGL2007Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetesNat Clin Pract Endocrinol Metab3465617179929
   PubMedGoogle Scholar
• RaymanGWilliamsSASpencerPD1986Impaired microvascular hyperaemic response to minor skin trauma in type 1 diabetesBr Med J292129582939920
   PubMed Web of Science ®Google Scholar
• ResinkTJHahnAWAScott-BurdenT1990Inducible endothelin messenger RNA expression and peptide secretion in cultured human vascular smooth muscle cellsBiochem Biophys Res Commun1681303102161221
   PubMed Web of Science ®Google Scholar
• RomeroMJiménezRSánchezM2008Quercetin inhibits vascular superoxide production induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKCAtherosclerosis316[Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• SakuraiTYanagisawaMMasakiT1992Molecular characterization of endothelin receptorsTrends Pharmacol Sci1310381315462
   PubMed Web of Science ®Google Scholar
• SandemanDDPymCAGreenEM1991Microvascular vasodilata-tion in feet of newly diagnosed non-insulin dependent diabetic patientsBr Med J302112232043783
   PubMedGoogle Scholar
• SasserJMSullivanJCHobbsJL2007Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanismJ Am Soc Nephrol181435417167119
   PubMed Web of Science ®Google Scholar
• SeoBOemarBSSiebenmannR1994Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vesselsCirculation89120388124808
   PubMed Web of Science ®Google Scholar
• SettergrenMPernowJBrismarK2008Endothelin-A receptor blockade improves nutritive skin capillary circulation in patients with type 2 diabetes and albuminuriaJ Vasc Res4529530218212505
   PubMed Web of Science ®Google Scholar
• ShoreACJaapAJTookeJE1994Capillary pressure in patients with NIDDMDiabetes4311982027926288
   PubMed Web of Science ®Google Scholar
• SirenALLewczukPHasselblattM2002Endothelin B receptor deficiency augments neuronal damage upon exposure to hypoxia-ischemia in vivoBrain Res945144912113963
   PubMed Web of Science ®Google Scholar
• StrachanFESprattJCWilkinsonIB1999Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy menHypertension3358159931169
   PubMed Web of Science ®Google Scholar
• TakahashiKGhateiMALamHC1990Elevated plasma endothelin in patients with diabetes mellitusDiabetologia33306102198188
   PubMed Web of Science ®Google Scholar
• ThrainsdottirSMalikRADahlinLB2003Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in manDiabetes5226152214514647
   PubMed Web of Science ®Google Scholar
• TookeJEHannemanMM2000Adverse endothelial function and the insulin resistance syndromeJ Int Med24742531
   PubMed Web of Science ®Google Scholar
• TookeJE1983Capillary pressure in non-insulin-dependent diabetesInt Angiol216771
   Google Scholar
• TookeJE1983Microvascular haemodynamics in diabetes mellitusClin Sci70119253514078
   PubMedGoogle Scholar
• TookeJE1995Microvascular function in human diabetes. A physiological perspectiveDiabetes4472167789639
   PubMed Web of Science ®Google Scholar
• TookeJE2000Possible pathophysiological mechanisms for diabetic angi-opathy in type 2 diabetesJ Diabetes Complications1419720011004428
   PubMed Web of Science ®Google Scholar
• TurEYosipovitchBar-OnY1991Skin reactive hyperaemia in diabetic patients. A study by laser Doppler flowmetryDiabetes Care14958621797508
   PubMed Web of Science ®Google Scholar
• TymmsDJTookeJE1988The effect of continuous subcutaneous insulin infusion (CSII) on microvascular blood flow in diabetes mellitusInt J Microcirc Clin Exp7347563220680
   PubMedGoogle Scholar
• VerhaarMCStrachanFENewbyDE1998Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockadeCirculation9775269498538
   PubMed Web of Science ®Google Scholar
• WalmsleyDWalesJKWilesPG1989Reduced hyperaemia following skin trauma: evidence for an impaired microvascular response to injury in the diabetic footDiabetologia3273692591641
   PubMed Web of Science ®Google Scholar
• WedgwoodSMcMullanDMBekkerJM2001Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapyCirc Res893576411509453
   PubMed Web of Science ®Google Scholar
• YanagisawaMKuriharaHKimuraS1988A novel potent vaso-constrictor peptide produced by vascular endothelial cellsNature332411152451132
   PubMed Web of Science ®Google Scholar
• ZanattaCMGerchmanFBurttetL2008Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitusDiab Res Clin Pract80299304
   PubMed Web of Science ®Google Scholar